- Report
- March 2024
- 132 Pages
Global
From €4232EUR$4,650USD£3,595GBP
- Report
- December 2022
- 150 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- March 2022
- 300 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- October 2018
- 30 Pages
China
From €2002EUR$2,200USD£1,701GBP
- Report
- December 2022
- 120 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- July 2022
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2024
- 160 Pages
Global
From €4523EUR$4,969USD£3,841GBP
- Report
- February 2024
- 160 Pages
Global
From €4523EUR$4,969USD£3,841GBP
- Report
- February 2024
- 180 Pages
Global
From €4523EUR$4,969USD£3,841GBP
- Report
- April 2021
- 148 Pages
Europe
From €3140EUR$3,450USD£2,667GBP
- Report
- April 2021
- 150 Pages
Asia Pacific
From €3140EUR$3,450USD£2,667GBP
- Report
- August 2024
- 80 Pages
Japan
From €3186EUR$3,500USD£2,706GBP
- Report
- April 2024
- 188 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2024
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- October 2023
- 89 Pages
Japan
From €3186EUR$3,500USD£2,706GBP
- Report
- September 2023
- 88 Pages
Israel
From €3186EUR$3,500USD£2,706GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2023
- 115 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- May 2023
- 87 Pages
Global
From €3181EUR$3,495USD£2,702GBP

Proton Pump Inhibitors (PPIs) are a class of drugs used to treat Gastrointestinal (GI) disorders. They work by reducing the amount of acid produced in the stomach, which helps to relieve symptoms of acid reflux, heartburn, and other GI conditions. PPIs are available in both prescription and over-the-counter forms, and are often used in combination with other medications to treat more severe GI conditions. Common side effects of PPIs include headache, nausea, and diarrhea.
PPIs are among the most widely prescribed drugs in the world, and are used to treat a variety of GI conditions. They are often used as a first-line treatment for acid reflux and other GI disorders, and are also used to prevent and treat ulcers.
Some of the major companies in the PPI market include AstraZeneca, Pfizer, Takeda, and GlaxoSmithKline. These companies produce a variety of PPIs, including omeprazole, lansoprazole, and pantoprazole. Show Less Read more